US FDA Approves Aurobindo Pharma’s Osteoarthritis Drug
Aurobindo Pharma’s, Aurolife Pharma LLC, has been granted final approval to manufacture and market Diclofenac Sodium Topical Solution by the US Food and Drug Administration (FDA). Horizon Therapeutics Ireland DAC (Horizon)’s Pennsaid Topical Solution, a reference listed drug (RLD), and the approved product are bioequivalent and therapeutically comparable. Osteoarthritis can be treated with Diclofenac Sodium […]
Continue Reading